Impact of COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: a possible role of the association to anti-CD20 antibody? A multicentre SEIFEM study

被引：0
|
作者：
Autore, Francesco
Visentin, Andrea
Deodato, Marina
Vitale, Candida
Galli, Eugenio
Fresa, Alberto
Fazzi, Rita
Sanna, Alessandro
Olivieri, Jacopo
Scortechini, Ilaria
del Principe, Maria Ilaria
Sportoletti, Paolo
Schiattone, Luana
Maschio, Nilla
Facchinelli, Davide
Coscia, Marta
Tedeschi, Alessandra
Trentin, Livio
Innocenti, Idanna
Candoni, Anna
Busca, Alessandro
Pagano, Livio
Laurenti, Luca
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1552495
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [41] Toxicity and efficacy of the anti-CD20 antibody rituximab (Rituxan™) in patients with B-cell chronic lymphocytic leukemia:: A phase I/II study.
    Winkler, U
    Schulz, HR
    Jensen, M
    Manzke, O
    Rüdiger, T
    Müller-Hermelink, KH
    Diehl, V
    Engert, A
    BLOOD, 1999, 94 (10) : 312A - 312A
  • [42] Progression of COVID-19 in a Patient on Anti-CD20 Antibody Treatment: Case Report and Literature Review
    Burgener, Sebastian
    Rochat, Philippe
    Dollenmaier, Guenter
    Benz, Gabriel
    Kistler, Andreas D.
    Fulchini, Rosamaria
    CASE REPORTS IN INFECTIOUS DISEASES, 2022, 2022
  • [43] Multicentre Phase 1 Study with an 8-Dose Regimen of Single Agent Anti-CD20 Monoclonal Antibody LFB-R603 in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)
    Cazin, Bruno
    Lepretre, Stephane
    Coiffier, Bertrand
    Aurran, Therese
    Cartron, Guillaume
    Feugier, Pierre
    Brehar, Oana
    Sadoun, Alain
    Segaud, Federic
    Ribrag, Vincent
    BLOOD, 2011, 118 (21) : 1234 - 1235
  • [44] Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Yoshioka, Satoshi
    Maruoka, Hayato
    Nasu, Seiko
    Nishioka, Tomomi
    Sakizono, Kenji
    Mitsuyuki, Satoshi
    Kubo, Tomoyo
    Okada, Naoki
    Nakagawa, Daishi
    Kamijo, Kimimori
    Imoto, Hiroharu
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Kondo, Tadakazu
    Miyakoshi, Chisato
    Doi, Asako
    Ishikawa, Takayuki
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [45] Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
    Masashi Nishikubo
    Yoshimitsu Shimomura
    Ryusuke Yamamoto
    Satoshi Yoshioka
    Hayato Maruoka
    Seiko Nasu
    Tomomi Nishioka
    Kenji Sakizono
    Satoshi Mitsuyuki
    Tomoyo Kubo
    Naoki Okada
    Daishi Nakagawa
    Kimimori Kamijo
    Hiroharu Imoto
    Yuya Nagai
    Nobuhiro Hiramoto
    Noboru Yonetani
    Tadakazu Kondo
    Chisato Miyakoshi
    Asako Doi
    Takayuki Ishikawa
    Blood Cancer Journal, 13
  • [46] Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Maruoka, Hayato
    Nasu, Seiko
    Sakizono, Kenji
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Kondo, Tadakazu
    Miyakoshi, Chisato
    Doi, Asako
    Ishikawa, Takayuki
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (03) : 821 - 825
  • [47] Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab
    Pickartz, T
    Ringel, F
    Wedde, M
    Renz, H
    Klein, A
    von Neuhoff, N
    Dreger, P
    Kreuzer, KA
    Schmidt, CA
    Srock, S
    Schoeler, D
    Schriever, F
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (12) : 1410 - 1416
  • [48] Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy
    Bazzi, Sam A.
    Maguire, Cole
    Holay, Nisha
    Geltman, Janelle
    Hurley, Kerin
    DiPasquale, Chris
    Abigania, Melissa
    Olson, Eric
    Ehrlich, Lauren I. R.
    Triplett, Todd A.
    Melamed, Esther
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [49] Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy
    Bazzi, Sam A.
    Maguire, Cole
    Holay, Nisha
    Geltman, Janelle
    Hurley, Kerin
    DiPasquale, Chris
    Abigania, Melissa
    Olson, Eric
    Ehrlich, Lauren I. R.
    Triplett, Todd A.
    Melamed, Esther
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [50] Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
    Azuly, Hovav
    Shafat, Tali
    Grupel, Daniel
    Porges, Tzvika
    Abuhasira, Ran
    Belkin, Ana
    Deri, Ofir
    Oster, Yonatan
    Zahran, Shadi
    Horwitz, Ehud
    Horowitz, Netanel A.
    Khatib, Hazim
    Batista, Marjorie Vieira
    Cortez, Anita Cassoli
    Brosh-Nissimov, Tal
    Segman, Yafit
    Ishay, Linor
    Cohen, Regev
    Atamna, Alaa
    Spallone, Amy
    Chemaly, Roy F.
    Ramos, Juan Carlos
    Chowers, Michal
    Rogozin, Evgeny
    Oren, Noga Carmi
    Keske, Siran
    Barchad, Orit Wolfovitz
    Nesher, Lior
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (01) : 167 - 180
12345